in 15%-20% of the cases. The main treatment strategy is surgery with protection of the healthy lung tissue as much as possible. However, recurrence rate is high. 1 Long-term medical treatment with mebendazole is preferred in unresectable, metastatic or recurrent disease and postoperative recurrence protection. 2 FDG-PET/CT is an important diagnostic method in the characterization of pulmonary lesions. It is known that FDG-PET has a high sensitivity for malignancy. However, intense FDG uptake can also be observed in many infective/inflammatory pathologies and it can reflect disease activity. 3, 4 FDG is considered an important biomarker for the evaluation of ecchinococcus alveolaris infections in studies which have been conducted in recent years as a new field. 5 The aim of this study was to investigate the role of FDG-PET/CT in the diagnosis and treatment of pulmonary hydatid disease and also compare the morphological characteristics of the lesions with SUVmax values and identify complicated disease.
| MATERIALS AND METHODS
Patients with the diagnosis of pulmonary hydatid disease between 2008 and 2017 were included in this retrospective study. Clinical, laboratory findings and available radiological examinations, surgical and pathological results, and clinical observation of patients were noted. CT and PET/CT images were re-evaluated.
The study included 36 patients with a total of 99 lesions. The lesions were classified as solid, semisolid, cystic and cavitary according to their morphological characteristics. Presence of capsule, border irregularity, air bubble and daughter cyst were evaluated in the lesions. Accompaying pleural and parenchymal findings such as pleural thickening, effusion, bronchial obstruction and consolidation were also noted. The size, HUmean and SUVmax values of the lesions were measured. FDG uptake of the mediastinal lymph nodes on PET/CT examination was recorded. Magnetic resonance, CT and ultrasonography (USG) examinations were reviewed to document liver lesions if present.
The relationship between size, HUmean values, lesion characteristics (cystic, solid, semisolid, cavitary, presence of border irregularity, encapsulated lesion), accompanying parenchymal (bronchial obstruction, consolidation) and pleural findings (pleural thickening and effusion) and SUVmax values of the lesions was evaluated. The relationship between lymphatic FDG uptake and morphologic characteristics, accompanying parenchymal and pleural findings was also analysed. Demographic data and lesion characteristics of the patients are presented in Table 1 .
Patients with single and multiple lesions were compared according to lesion size, location and coexistent liver lesion.
Thirty-three patients received surgical and medical teratment, three patients received only medical treatment.
| FDG PET/CT imaging
PET/CT evaluation was carried out with an integrated PET/CT scanner Siemens, Biograph-6-HI-REZ (Siemens Medical Solutions, Knoxville, TN USA). All patients fasted for at least 6 hours before the PET/CT imaging without water restiriction. After confirmation of an acceptable peripheral blood glucose level (<180 mg/dL), the patients were given an intravenous injection of 370-555 MBq (10-15 mCi) FDG and rested for 60 minutes before the scanning. First, the CT scan was performed from the top of skull to the proximal femur in the arms-up position. CareDose (Siemens) CT images were acquired with 130 kV, automatic, real-time dose modulation amperage, and slice thickness of 5 mm. Right after the CT scan, PET data were obtained for 3 minutes per bed position for a total of 6-8 bed positions. The CT data were used for attenuation correction. PET images were reconstructed using orderedsubsets expectation maximization algorithm with four iterations, eight subsets and a Gaussian post-filtering with a transaxial spatial resolution of 5 mm at full width at half maximum.
After the reconstruction of the images, SUVmax was obtained for semiquantitative analysis of FDG uptake. SUVmax reflects the degree of metabolic activity in a defined region of interest (ROIs). ROIs was drawn around the lesion on PET/ CT images. The SUVmax within the ROI was calculated automatically using the following equation: Tissue concentration (MBq∕mL) /injected FDG activity (MBq)/ body weight (g).
| Statistical analysis
Descriptive statistics were presented with frequency, percent, mean, standard deviation and median, minimum (min) and maximum (max) values. The relationship between lesion characteristics and SUVmax value of the lesions was evaluated by the Mann-Whitney U test. The relationship between lymphatic FDG uptake and lesion characteristics, accompanying parenchymal and pleural findings was evaluated by Fisher's exact test and Pearson chi-squared test. Spearman correlation test was used to evaluate the correlation between size, HUmean and SUVmax values. P values <0.05 were considered statistically significant. F I G U R E 1 A, On transaxial PET/CT images, there is a large cystic lesion with a thin peripheral capsule (white arrow) in the right lung and rim-style low intensity FDG uptake is observed in the peripheral regions of the lesion (dark arrow). B, There is a solid-type pulmonary nodule (white arrow) with markedly increased FDG uptake in the lower lobe of left lung (dark arrow). C, A small cavitary lesion in the superior segment of the lower lobe of the right lung (white arrow) and faint FDG uptake (dark arrow) on corresponding axial PET/CT slices are seen
| RESULTS
In this study, data of 36 patients (average age 53 ± 14 years; 17 female and 19 male) with a total of 99 lesions were retrospectively evaluated. Fourteen patients (14/36) had single and 22 patients (22/36) had multiple lesions. 7.1% of the lesions were solid, 53.5% were cystic ( Figure 1A ), 20.2% were semisolid ( Figure 1B ) and 19.2% were cavitary ( Figure 1C ). Thirty-two (32.3%) of the lesions were encapsulated. Thirty-eight (38.4%) of the lesions had a border irregularity. Nine (9.1%) of the lesions had air bubbles ( Figure 2A ) and 2 (2.02%) had daughter cysts ( Figure   2B ). Accompying consolidation in 10 (27.8%) patients ( Figure 2C ), bronchial obstruction in 9 (25%) patients, pleural thickening in 28 (77.8%) patients and pleural effusion in 3 (8.3%) patients were present. FDG uptake was detected in mediastinal lymph nodes in 27 (75%) patients. Fifty-one (51.5%) lesions were located in the right lung and 48 (48.5%) were located in the left lung. Eighteen of the 36 patients had coexistent liver lesions in which only one had FDG uptake (SUVmax:7.3). There was no significant difference in lesion distribution in both lungs, but lesions were predominantly located in the right lung (P = 0.02) when there was an accompanied liver lesion. When single F I G U R E 2 A, CT images of PET/CT scan show air bubbles in cystic lesions usually seen before perforation (white arrow). Peripheral lesions have higher FDG uptake than pure cystic lesions (dark arrow). B, Small daughter cysts in a large cyst are regarded as a sign of active disease (white arrow). Peripheral uptake of such a large lesion is observed at low intensity (dark arrow). C, Complicated disease and consolidation in the right lung (white arrow). Intense FDG uptake (dark arrow) is observed in this area because of the developing inflammation | OZMEN Et al.
and multiple lesions were compared, the mean age of the patients and lesion size were larger in cases with a single lesion (P = .02).
Mean size of the lesions was 2.91 ± 1.8 cm and mean SUVmax value was 3.14 ± 2.5. There was a positive correlation between HUmean and SUVmax values of lesions (r = 0.285). SUVmax values were significantly higher in solid (SUVmax: 6.1 ± 4.14), semisolid lesions (SUVmax: 4.76 ± 2.53) and lesions with border irregularity (SUVmax: 5.03 ± 2.67). SUVmax values of the lesions were higher in the presence of accompaying consolidation (P < .001), bronchial obstruction (P < .001) ( Table 2 ) and pleural thickening (P < .023). Lymphatic FDG uptake was also higher in these patients (P ≤ .009). SUVmax values and lymph node involvement were significantly lower in uncomplicated lesions such as cystic (P = .005) and encapsulated (P = .02). In our study, serology was revealed in 25 cases, 13 of them were positive. SUVmax values were higher but statistically insignificant in serologically positive patients than serologically negative group (P = .259). Thirty-three patients underwent operation (30 cystotomy capitonnage, 1 lobectomy, 1 pneumonectomy 1 wedge resection), while 3 patients had only received medical treatment.
| DISCUSSION
Pulmonary hydatid disease mostly occurs as solitary, cystic lesions in the right lower lobe of the lung. 6 In this study, 38.9% of the patients had a single lesion and the rate of cystic lesions was 53.5%. There was no significant difference in lesion distribution in both lungs. Synchronous involvement of lung and liver hydatid cysts is reported in the literature up to 25%. 7 In our study, coexistent lung and liver lesions were observed in 50% of the patients. Our patient group was composed of more complicated patients who were referred to our department with suspicion of malignancy. Therefore, the distribution and the morphological characteristics of the lesions were different from the literature. The main treatment choice is surgery in pulmonary hydatid disease. Adequate medical treatment after the operation is important to prevent recurrences and reduce complications. In addition, medical treatment with benzimidazoles is performed in cases where surgery can not be tolerated or is not accepted. Despite drug treatment, the rate of untreatable patients or recurrence is high. Besides, treatment has to be terminated in a group of patients because of side effects of medications. The clinician should know that parasite elimination is executed in order to make an effective and adequate treatment and terminate at the right time. Since the development of lesions in hydatid cyst is slow, evaluating the regression and progression after medical treatment is difficult and requires long follow-up. CT is an important imaging tool in the evaluation of lung lesions but additional new methods are needed to evaluate cyst viability. It has been reported that FDG-PET is an important technique for differentiating active and inactive liver lesions in alveolar echinococcosis. 8, 9 FDG-PET does not reflect parasitic activity directly. As in the case with other infective pathologies, imaging is based on the principle of viewing the cellular immunological response. Macrophages, lymphocytes, eosinophils, fibroblasts and myofibroblasts infiltrate around the lesion and perilesional FDG accumulation occurs as a result of cellular immunological response to parasites. 10 Active vesicles are more likely to stimulate the immune response and FDG uptake is thought to be higher for this reason. 11 It has been indicated that this imaging method may be helpful in discriminating active disease in the evaluation of treatment response and may guide the decision to terminate the treatment with benzimidazole. 8, 12 In our study, the lowest mean SUVmax values were detected in cystic lesions. However, rim-like FDG uptake in peripheral lesions could be easily distinguished. Like alveolar hidatid disease, perilesion FDG uptake may be a helpful parameter for assessing parasite viability in patients with pulmonary hidatid disease. Antibodies against circulating antigens in varying amounts depending on the disease state can be detected in 50%-80% of the patients (50-65% in pulmonary hydatid cyst). 13 Detection of circulating antigens is an important parameter for diagnosis, but it is insufficient in terms of evaluation of viability. In studies on echinococcus alveolaris infection, it has been stated that FDG uptake, as a quantitative parameter, may increase diagnostic accuracy by supporting serological methods. 14, 15 WHO expert consensus in 2007 reported that serology and PET-negativity after treatment were highly correlated with parasite inactivity. Neither serology nor PET negativity is the gold standard for a parasite's viabilites. However, in PET-negative patient group, relapses are less frequent after treatment. 16, 17 In our study, 25 cases revealed serology. Thirteen had positive serology with higher SUVmax values than the serology negative group. Further studies including larger patient series are necessary to confirm the correlation between serology and SUVmax and their predictive values. In our study, there was a positive correlation between the density of lesions, HUmean and SUVmax values. SUVmax values were low in cystic and encapsulated lesions and lymph node uptake was lesser in these group of patients. SUVmax values were significantly higher in solid and semisolid, irregularly bordered lesions and in lesions that have accompanying consolidation, bronchial obstruction and pleural thickening. Also, lymphatic uptake was higher in these patients. It has been shown in previous studies that increased cellular immunoreactivity and FDG uptake were directly proportional to the severity of infection and inflammation. 18, 19 If the lesions become complicated, SUV values increased depending on the inflammatory response. In accordance with the literature, higher SUV values were seen as a finding supporting complicated disease in our study. 20 Bilateral hydatid cysts can be treated by bilateral thoracotomy either in the same or different sessions. It is important to identify the priority of lesion. Cysts that are large, predisposing to trauma, causing symptoms and complications are preferential lesions for surgery. In addition to other decision-making parameters to determine the priority of lesions for surgery in cases with multiple lesions, FDG PET/CT may be helpful in detecting complicated lesions, which may improve therapeutic success ( Figure 3A-D) . Our study has some limitations because of its retrospective design. Since the growth of the lesions in pulmonary hydatid cysts is slow, evaluating the regression and progression after treatment is difficult and requires long follow-up. However, our patients did not have adequate follow-up. To achieve a more powerful conclusion about the prognostic value of SUVmax, increasing the follow-up period might be considered and new studies are needed.
| CONCLUSION
Higher SUVmax values may be a useful parameter in the diagnosis of complicated disease. FDG-PET may provide guidance for determining the priority of lesion for surgery in cases with multiple lesions and may be helpful to evaluate the response to medical treatment. Negative outcomes, especially in nonoperable patients, can be predictive for clinical management.
